# FDA Inspection 1102159 - Laboratorio Banco Vida - September 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/laboratorio-banco-vida/90af0a0b-1b8f-4dd2-b254-be0b0f600ede
Source feed: FDA_Inspections

> FDA Inspection 1102159 for Laboratorio Banco Vida on September 18, 2019. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102159
- Company Name: Laboratorio Banco Vida
- Inspection Date: 2019-09-18
- Classification: Official Action Indicated (OAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1148558 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/laboratorio-banco-vida/f384bc53-4982-4e3d-9972-d547f0ecc422)
- [FDA Inspection 1148558 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/laboratorio-banco-vida/7f1cf381-22d6-4d0a-81c2-a5d73754266f)

Company: https://www.keypedia.com/companies/laboratorio-banco-vida/1679ca95-a5b9-49ba-bc80-dccff43d708a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d